What is the Fiscal Year for Milestone Pharmaceuticals?
Date: November 14, 2026
Milestone Pharmaceuticals's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Montreal, QC
Industry
Biotechnology Research
Stock Symbol
MIST
Description
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a patient-centric commercial-stage biopharmaceutical company dedicated to bringing innovative cardiology products to market. Our lead product, CARDAMYST™ (etripamil), is FDA approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. We are also dedicated to the continued clinical investigation of etripamil as a treatment for atrial fibrillation with rapid ventricular rate (AFib-RVR). At Milestone, everything we do is with the patient in mind. To learn more, visit www.milestonepharma.com. Thank you for your interest in Milestone Pharmaceuticals. While we encourage you to explore opportunities with our company, we urge you to be cautious and wary of recruitment scams in which fraudsters pose as representatives of Milestone Pharma. All current openings are available to view on our Careers page. https://milestonepharmaceuticals.applytojob.com/
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Milestone Pharmaceuticals and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.